Market Overview:
The global flu shots market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth of the market can be attributed to the increasing incidence of influenza, rising demand for preventive measures against seasonal and pandemic influenza, and technological advancements in flu vaccine production. However, the high cost of vaccination and lack of awareness about vaccination are some factors that may restrain the growth of this market during the forecast period. The global flu shots market is segmented on the basis of type, application, and region. On the basis of type, it is divided into influenza virus split vaccines, influenza virus subunit vaccines, and influenza whole virus vaccines. Influenza virus split vaccines are further classified into trivalent vaccine and quadrivalent vaccine. Influenza subunit vaccines are further classified into monovalent vaccine and bivalent vaccine. Influenza whole virus vaccines are further classified into inactivated vaccine (IIV)and live attenuated nasal spray (LAIV). On the basis on application; it is segmented as avian influenzavirus-Aand avian influenzavirus-B .Geographically; it is analyzed across North America , Latin America , Europe Asia Pacific , Middle East & Africa . Some key players operating in this market include GlaxoSmithKline plc., Sanofi Pasteur SA., AstraZeneca plc., Johnson & Johnson Services Inc., MedImmune LLC.
Product Definition:
A flu shot is an injection of a vaccine that helps protect against the influenza virus. It is typically recommended for people who are at high risk of developing serious complications from the flu, including young children, pregnant women, and those with chronic health conditions such as asthma or diabetes. The vaccine works by prompting the body to produce antibodies that help fight off infection if you are exposed to the virus.
Influenza Virus Split Vaccines:
Influenza virus split vaccines are a new and innovative influenza vaccine that consists of two doses, one of them is a weakened or attenuated form of the other which gives it an advantage over conventional flu shots as it does not contain the other components like nephrotoxic mercury and aluminum salts. The second dose is made from frozen plasma.
Influenza Virus Subunit Vaccines:
Influenza virus subunit vaccines and it's usage in flu shots market is a new technology introduced by the pharmaceutical companies. The influenza virus consists of two types, namely the type A and type B viruses. Type A viruses are responsible for causing epidemic outbreaks such as swine flu (H1N1) while type B does not cause disease but can infect humans with severe disease conditions.
Application Insights:
Based on the application, the global flu shots market has been segmented into human influenza vaccine and animal Influenza vaccines. The human influenza vaccine segment dominated the overall market in terms of revenue share in 2017. This is due to a high demand for immunization against seasonal as well as novel strains of this disease. Moreover, novel technologies such as intradermal injection are being used for immunization against this disease which further boosts up its demand worldwide.
The animal Influenza vaccines segment is expected to grow at a lucrative rate over the forecast period owing to rising awareness among pet owners regarding protection of their animals from Avian Influenza through vaccination programs with these products.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, high awareness levels coupled with the highest spending power are some factors contributing to its growth. In addition, increasing incidence of seasonal diseases is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising target population base along with growing demand for immunization programs in emerging countries such as China and India. Furthermore, favorable government initiatives regarding vaccination programs are also expected boost revenue generation in this region over the next eight years.
Growth Factors:
- Increasing incidence of respiratory diseases: The increasing incidence of respiratory diseases, such as influenza, pneumonia, and bronchitis is a major growth driver for the flu shots market. According to the Centers for Disease Control and Prevention (CDC), each year in the U.S., 5-20% of the population suffers from seasonal flu and more than 36,000 people die from it.
- Growing awareness about preventive health measures: There is a growing awareness among people about preventive health measures, including vaccination against infectious diseases such as influenza. This is driving demand for flu shots worldwide.
- Rising number of elderly population: The global elderly population is rising rapidly due to increased life expectancy rates across the world. This is leading to an increase in cases of respiratory infections among this population segment, which is fueling demand for flu shots globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Flu Shots Market Research Report
By Type
Influenza Virus Split Vaccines, Influenza Virus Subunit Vaccines, Influenza Whole Virus Vaccines
By Application
Avian Influenza virus-A, Avian Influenza virus-B
By Companies
GSK, SINOVAC, CHANGSHENG, CCBIO, ALEPH BIOMEDICAL, SANOFI, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, SIOBP, HUALAN BIO, TIANYUAN BIO-PHARMA, VAXTEC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Flu Shots Market Report Segments:
The global Flu Shots market is segmented on the basis of:
Types
Influenza Virus Split Vaccines, Influenza Virus Subunit Vaccines, Influenza Whole Virus Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Avian Influenza virus-A, Avian Influenza virus-B
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- SINOVAC
- CHANGSHENG
- CCBIO
- ALEPH BIOMEDICAL
- SANOFI
- LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
- SIOBP
- HUALAN BIO
- TIANYUAN BIO-PHARMA
- VAXTEC
Highlights of The Flu Shots Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Influenza Virus Split Vaccines
- Influenza Virus Subunit Vaccines
- Influenza Whole Virus Vaccines
- By Application:
- Avian Influenza virus-A
- Avian Influenza virus-B
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Flu Shots Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Flu shots are a vaccine that helps protect people from the flu. They work by helping your body build immunity to the flu virus. Flu shots are typically given in fall and winter, when the risk of getting the flu is highest.
Some of the major players in the flu shots market are GSK, SINOVAC, CHANGSHENG, CCBIO, ALEPH BIOMEDICAL, SANOFI, LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT, SIOBP, HUALAN BIO, TIANYUAN BIO-PHARMA, VAXTEC.
The flu shots market is expected to grow at a compound annual growth rate of 7.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Flu Shots Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Flu Shots Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Flu Shots Market - Supply Chain
4.5. Global Flu Shots Market Forecast
4.5.1. Flu Shots Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Flu Shots Market Size (000 Units) and Y-o-Y Growth
4.5.3. Flu Shots Market Absolute $ Opportunity
5. Global Flu Shots Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Flu Shots Market Size and Volume Forecast by Type
5.3.1. Influenza Virus Split Vaccines
5.3.2. Influenza Virus Subunit Vaccines
5.3.3. Influenza Whole Virus Vaccines
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Flu Shots Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Flu Shots Market Size and Volume Forecast by Application
6.3.1. Avian Influenza virus-A
6.3.2. Avian Influenza virus-B
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Flu Shots Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Flu Shots Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Flu Shots Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Flu Shots Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Flu Shots Demand Share Forecast, 2019-2029
9. North America Flu Shots Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Flu Shots Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Flu Shots Market Size and Volume Forecast by Application
9.4.1. Avian Influenza virus-A
9.4.2. Avian Influenza virus-B
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Flu Shots Market Size and Volume Forecast by Type
9.7.1. Influenza Virus Split Vaccines
9.7.2. Influenza Virus Subunit Vaccines
9.7.3. Influenza Whole Virus Vaccines
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Flu Shots Demand Share Forecast, 2019-2029
10. Latin America Flu Shots Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Flu Shots Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Flu Shots Market Size and Volume Forecast by Application
10.4.1. Avian Influenza virus-A
10.4.2. Avian Influenza virus-B
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Flu Shots Market Size and Volume Forecast by Type
10.7.1. Influenza Virus Split Vaccines
10.7.2. Influenza Virus Subunit Vaccines
10.7.3. Influenza Whole Virus Vaccines
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Flu Shots Demand Share Forecast, 2019-2029
11. Europe Flu Shots Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Flu Shots Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Flu Shots Market Size and Volume Forecast by Application
11.4.1. Avian Influenza virus-A
11.4.2. Avian Influenza virus-B
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Flu Shots Market Size and Volume Forecast by Type
11.7.1. Influenza Virus Split Vaccines
11.7.2. Influenza Virus Subunit Vaccines
11.7.3. Influenza Whole Virus Vaccines
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Flu Shots Demand Share, 2019-2029
12. Asia Pacific Flu Shots Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Flu Shots Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Flu Shots Market Size and Volume Forecast by Application
12.4.1. Avian Influenza virus-A
12.4.2. Avian Influenza virus-B
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Flu Shots Market Size and Volume Forecast by Type
12.7.1. Influenza Virus Split Vaccines
12.7.2. Influenza Virus Subunit Vaccines
12.7.3. Influenza Whole Virus Vaccines
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Flu Shots Demand Share, 2019-2029
13. Middle East & Africa Flu Shots Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Flu Shots Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Flu Shots Market Size and Volume Forecast by Application
13.4.1. Avian Influenza virus-A
13.4.2. Avian Influenza virus-B
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Flu Shots Market Size and Volume Forecast by Type
13.7.1. Influenza Virus Split Vaccines
13.7.2. Influenza Virus Subunit Vaccines
13.7.3. Influenza Whole Virus Vaccines
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Flu Shots Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Flu Shots Market: Market Share Analysis
14.2. Flu Shots Distributors and Customers
14.3. Flu Shots Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GSK
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. SINOVAC
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CHANGSHENG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CCBIO
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ALEPH BIOMEDICAL
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. SANOFI
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCT
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. SIOBP
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. HUALAN BIO
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. TIANYUAN BIO-PHARMA
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. VAXTEC
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
